Skip to main content

RDY 226 Pill - white capsule/oblong, 13mm

Pill with imprint RDY 226 is White, Capsule/Oblong and has been identified as Lamotrigine (Chewable, Dispersible) 25 mg. It is supplied by Dr. Reddy’s Laboratories Inc.

Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 226

Lamotrigine (chewable, dispersible) 25 mg RDY 226
Lamotrigine (chewable, dispersible) 25 mg RDY 226

Lamotrigine (Chewable, Dispersible)

Imprint
RDY 226
Strength
25 mg
Color
White
Size
13.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC)
55111-0226
Inactive Ingredients
silicon dioxide, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, corn starch, saccharin sodium, magnesium silicate, black currant

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer